Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma
Among CK19+ HCC patients with higher recurrence of postoperative risk, PA-TACE could greatly improve RFS and OS.
Authors
- Can Zeng (ORCID: https://orcid.org/0000-0002-8039-4809)
- Yan Lin (ORCID: https://orcid.org/0000-0001-8034-5946)
- Hongyang Huang (ORCID: https://orcid.org/0000-0002-5138-7781)
- Guobin Wu (ORCID: https://orcid.org/0000-0003-0505-9637)
- Xiaobo Wang (ORCID: https://orcid.org/0000-0002-3311-1378)
- Rong-Yun Mai (ORCID: https://orcid.org/0009-0008-9830-0197)
- Tao Bai (ORCID: https://orcid.org/0000-0001-8056-6490)
- Jiazhou Ye (ORCID: https://orcid.org/0000-0001-9124-7284)
- Le‐Qun Li (ORCID: https://orcid.org/0000-0003-3224-4918)
- Rong Liang (ORCID: https://orcid.org/0000-0002-6419-9464)
- Tao Zheng (ORCID: https://orcid.org/0000-0001-9990-2693)
- K. C. Mo
- Dandan Zeng
Institutions
- Guangxi Medical University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/jhc.s537915
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Guangxi Medical University